InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Simmons Jeffrey N, Chairman & CEO. Director active across 1 companies, notably Elanco Animal Health Inc. In total, 7 filings have been logged. Total volume traded: €852k. The latest transaction was disclosed on 5 March 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€269,93210,688 shares@ €25.25560.0027% mcap13.3% of flow
Common Stock
SEC:0001415889-22-002744:0·
088,114 shares0
Common Stock
SEC:0001415889-22-002472:0·
0229,655 shares0
Common Stock
SEC:0001179110-22-001597:0·
€456,71315,814 shares@ €28.88030.0046% mcap51.7% of flow
Common Stock
SEC:0001179110-21-009594·
€456,71315,814 shares@ €28.88030.0046% mcap22.4% of flow
Common Stock
SEC:0001179110-21-009594:0·
€426,20416,850 shares@ €25.2940.0043% mcap48.3% of flow
Common Stock
SEC:0000950138-21-000410·
Ideal exit: 8 May 2022 (T+270)
€426,20416,850 shares@ €25.2940.0043% mcap20.9% of flow
Common Stock
SEC:0000950138-21-000410:0·
Ideal exit: 8 May 2022 (T+270)
7 of 7 declarations
About Simmons Jeffrey N
Jeffrey N. Simmons is the President, CEO & Director at Elanco Animal Health Inc. In this role, he is responsible for the strategic leadership of the company, including operations and product development. With extensive experience in the animal health sector, he guides the company towards innovation and growth. His leadership is essential for achieving the organization's objectives and strengthening its market position.
